Drug-drug Interaction (DDI) Rifabutin

NCT02138084 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: BMS-663068
DRUG: Rifabutin
DRUG: Ritonavir

Sponsor

ViiV Healthcare

Collaborators

[object Object]